Pharmacokinetic studies in volunteers with renal impairment

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 11, 1998, Pages 594-598

  Keller, F ^a   Czock, D ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Pharmacodynamics; Pharmacokinetics; Renal impairment; Volunteer

Indexed keywords

CREATININE;

ANURIA; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISTRIBUTION VOLUME; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; PHARMACOKINETICS;

AGED; AGING; CLINICAL TRIALS; CREATININE; HUMANS; KIDNEY FAILURE; METABOLIC CLEARANCE RATE; PATIENT SELECTION; PHARMACOKINETICS; PHARMACOLOGY; VOLUNTARY WORKERS;

EID: 0031797636     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
2. Dettli L 1976 Drug dosage in renal disease. Clin Pharmacokinet 1: 126-134
3. Gloff CA, Benet LZ 1989 Differential effects of the degree of renal damage on p-aminohippuric acid and inulin clearance in rats. J Pharmacokinet Biopharm 17: 169-177
4. Haegele KD, Huebert ND, Ebel M, Tell GP, Schechter PJ 1988 Pharmacokinetics of vigabatrin: implications of creatinine clearance. Clin Pharmacol Ther 44: 558-565
5. Hoeffler D, Koeppe P 1993 Nonrenal clearance and tubular load in renal failure. Arzneimittelforschung 11: 1233-1238
6. Keller F, Erdmann K, Giehl M, Buettner P 1993 Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin. Clin Pharmacokinet 25: 71-79
7. Keller F, Giehl M, Frankewitsch T, Zellner D, Simon S 1996 Overlooked decrease in renal function as a major reason for adverse drug reactions in the elderly. Eur J Intern Med 7: 211-215
8. Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U 1997 Pharmacokinetic (PK) and pharmacodynamic (PD) assessment of midazolam in elderly dental patients. Eur J Clin Pharmacol 52 (Suppl): A81
9. Rakhit A, Radensky P, Szerlip HM, Kochak GM, Audet PR, Hurley ME, Feldman GM 1988 Effect of renal impairment on disposition of pentopril and its active metabolite. Clin Pharmacol Ther 44: 39-48
10. Schmith VD, Piramino B, Smith RB, Kroboth PD 1992 Alprazolam in end-stage renal disease: II pharmacodynamics. Clin Pharmacol Ther 51: 533-540
11. Vanholder R, van Landschoor N, de Smet R, Schoots A, Ringoir S 1988 Drug protein binding in chronic renal failure: evaluation of nine drugs. Kidney Int 33: 996-1004
12. Voehringer HF, Rietbrock N 1981 Digitalis therapy in renal failure with special regard to digitoxin. Int J Clin Pharmacol Ther Toxicol 19: 175-184